Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
More than 500 medtech policy missives were recorded in Pathways’ Document Depot in 2024, coming from every continent except Antarctica. Here, with honorable mentions, are our top 10 documents of the year, countdown style.
Three MedTech Innovator cohort companies offer noninvasive devices for treatment and monitoring of chronic conditions.
FDA issued 31 draft and final guidance documents on January 6, just two weeks before the current HHS/FDA leadership exits and the Trump administration takes power. Several of the documents in particular should be on device companies’ radar: Excerpted from Pathways’ Picks January 8: FDA Guidance Bonanza, Diversity Action Plans, and Global Picks.